RAB14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.44089209850063E-15 |
Normal-vs-Stage2 |
6.63779999965364E-07 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
7.550600E-01 |
Stage1-vs-Stage3 |
2.11800000005091E-06 |
Stage1-vs-Stage4 |
1.79626999999849E-05 |
Stage2-vs-Stage3 |
3.690400E-02 |
Stage2-vs-Stage4 |
2.801700E-02 |
Stage3-vs-Stage4 |
7.242000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62458935193399E-12 |
Normal-vs-AfricanAmerican |
4.08451050759595E-12 |
Normal-vs-Asian |
1.342220E-02 |
Caucasian-vs-AfricanAmerican |
9.539600E-01 |
Caucasian-vs-Asian |
3.307000E-01 |
AfricanAmerican-vs-Asian |
3.137400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.63979940737136E-12 |
Male-vs-Female |
2.156000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.64720004303121E-09 |
Normal-vs-Age(41-60Yrs) |
3.77475828372553E-15 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
1.62699997918736E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.240400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.345400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.026600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.061700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.294000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.213600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.265600E-02 |
Normal-vs-Grade 2 |
4.19110302019021E-11 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
2.320400E-01 |
Grade 1-vs-Grade 3 |
1.360000E-03 |
Grade 1-vs-Grade 4 |
8.46910000000811E-05 |
Grade 2-vs-Grade 3 |
2.81540000002245E-06 |
Grade 2-vs-Grade 4 |
2.10509999987174E-07 |
Grade 3-vs-Grade 4 |
1.947830E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.48340006944636E-10 |
Normal-vs-ccB subtype |
1.62458935193399E-12 |
ccA subtype-vs-ccB subtype |
2.11409999999468E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62636570877339E-12 |
Normal-vs-N1 |
8.25570000140274E-08 |
N0-vs-N1 |
2.976800E-01 |
|
|